Orange Book product · Generic (ANDA)
ACITRETIN
ACITRETIN
Generic (ANDA)ANDA 202897TE ABRX TEVA PHARMS USA
At a glance
Apr 04, 2013
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 04, 2013
13 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
ACITRETIN
Strength
17.5MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 202897
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ACITRETIN
- 1996SORIATANEBrand (NDA)
NDA 019821 · STIEFEL LABS INC
- 2024ACITRETINGeneric (ANDA)
ANDA 217774 · ALEMBIC
- 2015ACITRETINGeneric (ANDA)
ANDA 202552 · IMPAX LABS INC
- 2015ACITRETINGeneric (ANDA)
ANDA 202148 · MYLAN
- 2015ACITRETINGeneric (ANDA)
ANDA 203707 · MYLAN
- 2015ACITRETINGeneric (ANDA)
ANDA 204633 · SIGMAPHARM LABS LLC
- 2013ACITRETINGeneric (ANDA)
ANDA 091455 · BARR LABS INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
